When Should You SELL Your Stocks (8 Reasons to Sell Your Stocks) Click to watch on Youtube.

Lexicon Pharmaceuticals Stock Forecast

NASDAQ:LXRX BUY

$2.83 (5.20%)

Volume: 2.74M

Closed: Aug 05, 2022

Hollow Logo Score: 3.104

Lexicon Pharmaceuticals Stock Forecast

BUY NASDAQ:LXRX
$2.83 (5.20%)

Volume: 2.74M

Closed: Aug 05, 2022

Score Hollow Logo 3.104
Which way will LXRX go? Request
Fri, Aug 05, 2022 Buy Candidate
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSI min/max Values: [ 25 - 75 ] RSI14 is 50 and the stock is currently not being overbought or oversold
Last Reaction
Be the first to comment on LXRX

Big movements in Lexicon Pharmaceuticals stock price on Friday moving 10.76% between high and low
(Updated on Aug 05, 2022)


Buy candidate since 2022-08-02 Gain 8.85% PDF

The Lexicon Pharmaceuticals stock price gained 5.20% on the last trading day (Friday, 5th Aug 2022), rising from $2.69 to $2.83. During the last trading day the stock fluctuated 10.76% from a day low at $2.60 to a day high of $2.88. The price has risen in 5 of the last 10 days, but is still down by -8.12% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 742 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $7.75 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 86.12% during the next 3 months and, with a 90% probability hold a price between $4.16 and $6.42 at the end of this 3-month period.

Signals & Forecast

The Lexicon Pharmaceuticals stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.57 and $2.55. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 27, 2022, and so far it has fallen -13.46%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

Lexicon Pharmaceuticals finds support from accumulated volume at $2.75 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.28 between high and low, or 10.76%. For the last week, the stock has had a daily average volatility of 6.91%.

Our recommended stop-loss: $2.66 (-6.00%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday 8th we expect Lexicon Pharmaceuticals to open at $2.77, and during day (based on 14 day Average True Range), to move between $2.59 and $3.07, which gives a possible trading interval of +/-$0.24 (+/-8.65%) up or down from last closing price. If Lexicon Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 17.31% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.87 (1.41%) than the support at $2.75 (2.83%), our systems don't find the trading risk/reward intra-day attractive and any bets should be hold until the stock is closer to the support level.

Is Lexicon Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Lexicon Pharmaceuticals stock to perform well in the short-term.

Current score: 3.104

Buy Candidate Unchanged

Predicted Opening Price for Lexicon Pharmaceuticals of Monday, August 8, 2022

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price August 8, 2022 Current price
$2.77 $2.83 (Overvalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 3.05 7.77 %
2.94 3.99 %
2.88 1.66 %
Current price: 2.83
Support 2.66 -5.90 %
2.60 -8.23 %
2.49 -12.01 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 3.08 8.83 %
2.96 4.59 %
2.87 1.41 %
Current price 2.83
Support 2.75 -2.83%
2.40 -15.19%
2.24 -20.85%

Click to get the best stock tips daily for free!

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The compan... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT